Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (1) , 50-55
Abstract
Background. The incidence and associated morbidity of Clostridium difficile (CD) infection has been increasing at an alarming rate in North America. ClostridiumKeywords
This publication has 18 references indexed in Scilit:
- Microbial Influences in Inflammatory Bowel DiseasesGastroenterology, 2008
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Impact of Clostridium difficile on Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2007
- Recommendations for Surveillance of Clostridium difficile–Associated DiseaseInfection Control & Hospital Epidemiology, 2007
- tcdC Genotypes Associated with Severe TcdC Truncation in an Epidemic Clone and Other Strains of Clostridium difficileJournal of Clinical Microbiology, 2007
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeThe Lancet, 2005
- Clostridium difficile ColitisNew England Journal of Medicine, 1994